Outcome measure | Measurement timepoints & methods |
---|---|
Primary outcome | Â |
Proportion of participants obtaining influenza vaccination during the study | • Study completion1 (via self-reports and clinical audit) |
Secondary outcome | Â |
Proportion of participants visiting the University Health Service during the study | • Study completion1 (via self-reports and clinical audit) |
Ancillary outcomes | Â |
Proportion of participants experiencing symptoms of influenza-like illness 2 (ILI) during the study | • Monthly from study commencement in May to October 2010 (via self-reports) |
Proportion of participants using medications or remedy due to ILI symptoms 2 | • Monthly from study commencement in May to October 2010 (via self-reports) |
Proportion of participants visiting a healthcare professional due to ILI symptoms 2 | • Monthly from study commencement in May to October 2010 (via self-reports) |
Proportion of participants experiencing impairment in work or study due to ILI symptoms 2 | • Monthly from study commencement in May to October 2010 (via self-reports) |
Number of days absent from work or study due to ILI symptoms (per participant) | • Monthly from study commencement in May to October 2010 (via self-reports) |
Reasons for receiving (or not receiving) influenza vaccine | • Study completion1 (via self-reports) |
Patterns of usage and feedback of PCHMS | • Study completion1 (via automatic system logs, data entered by participants into PCHMS, and self-reports) |